AuntMinnie.com staff writers

Molecular Imaging
CMS delays decision on amyloid PET coverage
The U.S. Centers for Medicare and Medicaid Services (CMS) plans to take more time to review evidence in deciding whether to change coverage for amyloid PET scans for patients in clinical trials.
December 15, 2022
2022 01 12 18 18 1479 Patient Elderly Confused Headache 400
AI
PaxeraHealth secures series A funding
PaxeraHealth has closed a series A funding round led by Sopris Capital. The company plans to use the funds to continue development of its medical imaging AI algorithms.
December 15, 2022
2021 04 29 16 55 9257 Fist Cash 400
Industry News
ASRT bestows $25K research grant
The American Society of Radiologic Technologists (ASRT) Foundation has bestowed a $25,000 research grant to a team from Mount Sinai Health System in New York City.
December 15, 2022
2020 10 15 21 42 4157 Money Bag Grant Award 400
Molecular Imaging
XingImaging, Mitro to join forces on expanding Chinese services
XingImaging and molecular imaging company Mitro Biotech will collaborate to provide contract research services in China, aiming to work with global pharmaceutical and biotechnology companies.
December 14, 2022
2021 09 14 23 49 7847 Business Handshake 400
CT
Availability of mobile CT systems increases in Asia-Pacific
NeuroLogica, a subsidiary of Samsung Electronics, is highlighting the installation of its SmartMSU with the OmniTom Elite for mobile head CT imaging in the Asia-Pacific region.
December 14, 2022
2022 06 06 23 29 1561 Ambulance Emergency Night 400
Molecular Imaging
Siemens Healthineers rebrands Corindus
Siemens Healthineers said its company Corindus will be rebranded as Siemens Healthineers Endovascular Robotics.
December 13, 2022
2021 11 28 20 00 6152 Siemens Rsna 2021 400
Industry News
RSNA reports nearly 38K registrations at 2022 meeting
The RSNA reported nearly 38,000 registrations -- both virtual and in-person -- at its recent annual meeting in Chicago.
December 13, 2022
2022 11 28 16 17 2543 Rsna 2022 Welcome 400
Industry News
US Radiology expands partnership with Scanslated
US Radiology Specialists will offer Scanslated's patient-centered radiology reporting service at more of its outpatient imaging centers across the country.
December 13, 2022
2022 09 09 22 43 4643 Computer Doctor Report Digital 400
Nuclear Medicine
Companies ink deal to develop OncoFAP-23
Philochem has signed agreements with Seibersdorf Laboratories and Isotopia Molecular Imaging to develop its lutetium-177 OncoFAP-23 radiopharmaceutical for cancer treatment.
December 13, 2022
2018 12 11 00 02 7009 Atom Nuclear Lab 400
AI
Flywheel forms federated data network for breast imaging AI
Research informatics company Flywheel is creating a federated data network to support large-scale research and collaboration involving breast imaging artificial intelligence (AI) technology.
December 13, 2022
2022 11 09 00 22 8746 Artificial Intelligence Ai Abstract Futuristic 400
Previous Page
Page 65 of 3774
Next Page
Top Stories
Amyloid
Molecular Imaging
Visual reads of amyloid PET scans effective in real-world settings
The findings support the use of amyloid PET scans as acquired and visually read in the real world.
Plaque Artery
MRI
MRI reveals effects of ultraprocessed food on the heart
Doctor Sad Lean Wall
Practice Management
ASRT survey shows vacancy rates still high among imaging departments
Ai Bias
Digital X-Ray
Can eye gaze data from radiologists make AI more human?
When time is of the essence
Sponsor Content
When time is of the essence
More in Home
Ultrasound test detects 96% of ovarian cancers
By Kate Madden Yee
An ultrasound test can identify 96% of ovarian cancers in postmenopausal women, researchers have reported.
October 1, 2024
Ovarian Cancer
ACS: Breast cancer mortality decreases, disparities persist
By Amerigo Allegretto
A new ACS report found that although overall breast cancer mortality continues to decline, racial and ethnic disparities persist.
October 1, 2024
Breast Mammo 400
PET identifies risk of metastases in patients with HNSCC
By Will Morton
PET imaging with F-18 fluoromisonidazole can determine whether cancer may spread in patients undergoing chemoradiotherapy for head and neck squamous cell carcinoma (HNSCC).
October 1, 2024
Headandneck2
ASTRO: Timing key to adding immunotherapy to chemoradiation
By Amerigo Allegretto
Timing may be key when adding immunotherapy to chemoradiation for lung cancer treatment.
October 1, 2024
Lung Cancer
ASTRO: Black patients voice distrust in medical research
By Will Morton
Spiritual beliefs and a distrust of clinical research may partly explain why Black patients choose not to participate in cancer trials.
September 30, 2024
Black Patient
ASTRO: IMRT and proton therapy equally effective for prostate cancer
By Will Morton
Intensity-modulated radiation therapy (IMRT) and proton therapy offer equally high quality of life and tumor control for people with prostate cancer.
September 30, 2024
Prostate Imaging
AuntMinnie 2015: CMS issues final CT lung cancer screening approval
By Eric Barnes
In 2015, our most popular article reported on the final CMS decision memo for reimbursement of CT lung cancer screening.
September 30, 2024
Am Logo Main 25 Anniversary Thumbnail 66635a3c44252 66ae4e8a1f10e
ASTRO: Lu-177 dotatate shows promise for treating meningioma patients
By Kate Madden Yee
A radiopharmaceutical therapy that lengthens progression-free survival for patients with neuroendocrine cancer could help treat meningioma sufferers.
September 30, 2024
Brain
ASTRO: Brain cancer patients treated by radiation recoup cognitive function
By Kate Madden Yee
Patients with brain metastases who experience cognitive side effects after radiation therapy appear to eventually regain cognitive function.
September 30, 2024
Brain Puzzle Dementia
FDA approves flurpiridaz F-18 PET tracer for imaging heart disease
By Will Morton
The U.S. Food and Drug Administration (FDA) approved the radiotracer flurpiridaz F-18 September 27 for PET imaging of coronary artery disease.
September 27, 2024
Fda
Can men with negative prostate MRI skip systematic biopsy?
By Kate Madden Yee
Skipping systematic biopsy in men with elevated prostate-specific antigen (PSA) levels but negative MRI results reduces overdiagnosis by more than 50%.
September 26, 2024
Prostate Cancer 3 D Rendering
GAE could be cost-effective for knee osteoarthritis
By Will Morton
Genicular artery embolization (GAE) is likely a cost-effective treatment for symptomatic knee osteoarthritis.
September 26, 2024
Knee
Previous Page
Page 65 of 160
Next Page